Overwhelming medical evidence exists that the vast majority of affected children will spontaneously realign their gender identity with their biological sex when left alone
WASHINGTON, D.C -- Drugs that are being used as a puberty blocker in gender-confused youth have been linked to tens of thousands of serious reactions and thousands of deaths, as well as other serious medical issues, according to Food & Drug Administration (FDA) data.
The FDA has now documented over 41,000 adverse reactions suffered by patients who took Leuprolide Acetate, known as Lupron, which is used as a hormone blocker. There have been 25,645 reactions considered “serious,” including 6,379 deaths.
Lupron is traditionally used for treatment of prostate cancer as it inhibits the flow of testosterone over the prostate. The drug is clinically approved for treatment of precocious puberty, a condition where children start their pubertal processes at an abnormally early age and the blocker is administered for a short time until the proper age. However, it is being prescribed off-label for use in children who have been diagnosed with gender dysphoria, despite the lack of formal FDA approval for that purpose and the absence of any peer-reviewed studies done on the drug's long-term effects.